Other
Ultrasound
0
Pipeline Programs↗
22
Active Trials↗
1
Companies Involved↗
Ultrasound is an early-stage landscape with 0 programs across 1 company. The most active players are Chiesi Poland Sp. z o.o..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
112
clinical trials
Completed48 · 43%
Unknown status24 · 21%
Terminated13 · 12%
Recruiting12 · 11%
Not yet recruiting6 · 5%
Withdrawn4 · 4%
Other5 · 4%
Clinical Trials
Trial Activity
112 trials
Contribution of Contrast Enhanced Ultrasound for Diagnosis of Adnexal Torsion
Recruiting·—·Phase 3·NCT06677554·256 enrolled
Study of Placental Vascularization Using Contrast Ultrasound
Recruiting·—·Phase 3·NCT06497959·30 enrolled
Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors
Recruiting·—·Phase 2·NCT06261814·266 enrolled
Effective Dose and Safety of Esketamine During Ultrasound-guided Hepatic Tumor Thermal Ablation
Active, not recruiting·TThe First Affiliated Hospital of Xiamen University·Phase 1/2·NCT07034950·79 enrolled
Transvaginal Three-Dimensional Ultrasound for Evaluation of Intrauterine Device Position Six Weeks After Insertion
Not yet recruiting·—·N/A·NCT07138248·138 enrolled
Page 1 of 8
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)